ONCIMMUNE HOLDINGS PLC Logo

ONCIMMUNE HOLDINGS PLC

Antibody biomarker discovery platform for pharma and biotech partners in oncology and autoimmune disease.

ONC | IL

Overview

Corporate Details

ISIN(s):
GB00BYQ94H38
LEI:
213800HCYIWT6YPI1I02
Country:
United Kingdom
Address:
CLINICAL SCIENCES BUILDING CITY HOSPITAL, NG5 1PB NOTTINGHAM
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Oncimmune Holdings PLC is a precision medicine company specializing in antibody biomarker discovery to support the development of targeted therapies. Its core offering is the proprietary ImmunoINSIGHTS™ platform, an analytical engine that profiles autoantibodies from minimal biological samples. Leveraging one of the world's largest antigen libraries (over 9000 antigens), high-throughput automated workflows, and advanced bioinformatics, the platform provides insights for pharmaceutical and biotechnology partners. The company's services focus on biomarker discovery and targeted panels for applications in immuno-oncology, autoimmune diseases, and infectious diseases, aiming to enable more effective and safer treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-26 13:45
Legal Proceedings Report
Appointment of Administrators & Nomad Resignation
English 9.0 KB
2025-03-19 08:00
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-03-17 08:00
Delisting Announcement
Intention to Appoint Administrators and Suspension
English 11.4 KB
2025-03-14 08:00
Share Issue/Capital Change
Block Listing Return
English 12.3 KB
2025-03-10 14:39
Post-Annual General Meeting Information
Result of GM
English 14.5 KB
2025-02-27 17:18
Post-Annual General Meeting Information
Result of AGM
English 13.5 KB
2025-02-24 08:00
Business and Financial Review
Strategic update
English 11.1 KB
2025-02-18 08:00
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-02-12 08:01
Share Issue/Capital Change
Block Listing Return
English 12.3 KB
2025-02-12 08:00
Pre-Annual General Meeting Information
Posting of Notice of General Meeting
English 8.1 KB
2025-02-10 08:00
Earnings Release
Final Results
English 154.5 KB
2025-02-04 11:38
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB
2025-02-03 08:00
Pre-Annual General Meeting Information
Notice of Annual General Meeting
English 8.2 KB
2025-01-31 08:00
Earnings Release
Trading Update
English 13.6 KB
2024-12-10 16:36
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB

Automate Your Workflow. Get a real-time feed of all ONCIMMUNE HOLDINGS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ONCIMMUNE HOLDINGS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
FARON PHARMACEUTICALS OY Logo
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland FARN
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI
Genomic Vision Logo
Develops DNA analysis tools using Molecular Combing for genetic research and diagnostics.
France GV
Genxone Spolka Akcyjna Logo
A biotech firm offering nanopore DNA/RNA sequencing services and medical diagnostics.
Poland GX1
Hamlet BioPharma AB Logo
Developing selective therapies for cancer and infections like bladder cancer and UTIs.
Sweden HAMLET
Hipower Energy Spolka Akcyjna Logo
Develops hydrogen solutions, mobile refueling, and CO2-to-methanol tech for energy markets.
Poland HPE

Talk to a Data Expert

Have a question? We'll get back to you promptly.